Abstract:Background Clinical prediction models have been developed for hospitalization for heart failure in type 2 diabetes. However, a systematic evaluation of these models' performance, applicability, and clinical impact is absent. Methods and Results We searched Embase, MEDLINE, Web of Science, Google Scholar, and Tufts' clinical prediction registry through February 2021. Studies needed to report the development, validation, clinical impact, or update of a prediction model for hospitalization for heart failure in type 2 diabetes with measures of model performance and sufficient information for clinical use. Model assessment was done with the Prediction Model Risk of Bias Assessment Tool, and meta‐analyses of model discrimination were performed. We included 15 model development and 3 external validation studies with data from 999 167 people with type 2 diabetes. Of the 15 models, 6 had undergone external validation and only 1 had low concern for risk of bias and applicability (Risk Equations for Complications of Type 2 Diabetes). Seven models were presented in a clinically useful manner (eg, risk score, online calculator) and 2 models were classified as the most suitable for clinical use based on study design, external validity, and point‐of‐care usability. These were Risk Equations for Complications of Type 2 Diabetes (meta‐analyzed c‐statistic, 0.76) and the Thrombolysis in Myocardial Infarction Risk Score for Heart Failure in Diabetes (meta‐analyzed c‐statistic, 0.78), which was the simplest model with only 5 variables. No studies reported clinical impact. Conclusions Most prediction models for hospitalization for heart failure in patients with type 2 diabetes have potential concerns with risk of bias or applicability, and uncertain external validity and clinical impact. Future research is needed to address these knowledge gaps. Nonstandard Abbreviations and Acronyms ACCORD Action to Control Cardiovascular Risk in Diabetes trial HHF hospitalization for heart failure PROBAST Prediction Model Risk of Bias Assessment Tool RECODe Risk Equations for Complications of Type 2 Diabetes TRS‐HF DM Thrombolysis in Myocardial Infarction Risk Score for HF in Diabetes WATCH‐DM (Weight [BMI], Age, Hypertension, Creatinine, HDL‐C, Diabetes Control [fasting plasma glucose], QRS Duration, MI, and CABG) risk score Clinical Perspective What Is New? Available evidence suggests that several widely available clinical risk tools can robustly prognosticate the risk of heart failure hospitalization in people with type 2 diabetes and identify those who may benefit most from novel guideline‐directed medical therapies. The effect of most clinical prediction models on clinical outcomes, patient care, provider behaviors has largely been under investigated, as a result, health, economic, and clinical investigations of these tools are warranted. What Are the Clinical Implications? Given that several clinical prediction models have demonstrated robust prognostic accuracy, their implementation in clinical settings might facilitate the identification of high‐risk individuals with type 2 diabetes who may benefit most from guideline‐directed therapies such as sodium‐glucose co‐transporter 2 inhibitors. Type 2 diabetes (T2D) contributes to >1.5 million annual deaths worldwide. 1 This high rate of mortality can be partly attributed to the metabolic alterations that precipitate diabetic cardiomyopathy and its attendant complications. 2 Correspondingly, the development of heart failure (HF) has emerged as one of the most common and important manifestations of cardiovascular disease in individuals with diabetes. 3 The concern over HF initially stemmed from safety troubles with certain antidiabetic treatments (eg, thiazolidinediones), and the fact that hospitalizations for heart failure (HHF) portend a poor prognosis. 4 , 5 Thus, the use of prediction models for identifying patients with diabetes at particularly high risk for developing HF -Abstract Truncated-

Impact of Residential Social Deprivation on Prediction of Heart Failure in Patients With Type 2 Diabetes: External Validation and Recalibration of the WATCH-DM Score Using Real World Data

Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score

The WATCH-DM risk score estimates clinical outcomes in type 2 diabetic patients with heart failure with preserved ejection fraction

Implications of Social Disadvantage Score in Cardiovascular Outcomes and Risk Assessment: Findings From the Multi-Ethnic Study of Atherosclerosis

190-OR: Development and Validation of a Social Risk Screening Tool for Adults with Type 2 Diabetes

Heart Failure Risk Prediction in a Population With a High Burden of Diabetes: Evidence From the Strong Heart Study

WATCH-DM risk score predicts the prognosis of diabetic phenotype patients with heart failure and preserved ejection fraction

Development and Validation of a County-Level Social Determinants of Health Risk Assessment Tool for Cardiovascular Disease

Socioeconomic Deprivation: An Important, Largely Unrecognized Risk Factor in Primary Prevention of Cardiovascular Disease

A machine learning tool for identifying newly diagnosed heart failure in individuals with known diabetes in primary care

Prediction of cardiovascular risk in patients type 2 diabetes using the SCORE2-Diabetes risk score

Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta‐Analysis

A multiparametric heart failure score at baseline is associated with long-term outcome in patients with remotely monitored implantable cardioverter-defibrillators: A pooled analysis of 9 clinical trials

Validation of existing risk scores for worsening renal function in patients with newly diagnosed heart failure: a longitudinal population cohort study

Association Between Socioeconomic Disadvantage and Risks of Early and Recurrent Admissions Among Patients With Newly Diagnosed Heart Failure

A Risk Prediction Model for Heart Failure Hospitalization among Patients with Type 2 Diabetes

Comparison of prediction models for cardiovascular and mortality risk in people with type 2 diabetes: An external validation in 23 685 adults included in the UK Biobank

Neighborhood Disadvantage and Risk of Heart Failure: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study

A risk prediction model for heart failure hospitalization in type 2 diabetes mellitus

Derivation and validation of a prediction score for major coronary heart disease events in a U.K. type 2 diabetic population

Addition of Social Determinants of Health to Coronary Heart Disease Risk Prediction: The Multi‐Ethnic Study of Atherosclerosis